Vivo Opportunity LLC 13D/13G Filings for Viridian Therapeutics, Inc. (VRDN)

Vivo Opportunity LLC 13D and 13G filings for Viridian Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
5:45 pm
Purchase		 2022-12-31 13G Viridian Therapeutics, Inc.
VRDN		 Vivo Opportunity LLC 1,678,207
4.200%		 378,207increase
(+29.09%)		 Filing
2021-09-30
4:30 pm
Purchase		 2021-09-21 13G Viridian Therapeutics, Inc.
VRDN		 Vivo Opportunity LLC 1,300,000
7.700%		 1,300,000increase
(New Position)		 Filing